# MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment

> **NCT00885027** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1342 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00885027
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-04
- **Final completion:** —
- **Target enrollment:** 1342 (ACTUAL)
- **Last updated:** 2013-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00885027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00885027, "MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00885027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*